Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

New
New Allied Market Research

Digital PCR Market by Technologies (Droplet Digital PCR, Chip Based Digital PCR and BEAMing Digital PCR), Product Type (Digital PCR Systems, Consumables & Reagents, and Software & Services), Application (Research, Clinical Diagnostics, and Forensic & Others), and End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, and Universities & Other Organizations): Global Opportunity Analysis and Industry Forecast, 2021-2028

A00532
Pages: 249
Apr 2021 | 11111 Views
 
Author(s) : Smita Nerkar, Trupti Wadekar , Onkar Sumant
Tables: 147
Charts: 39
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Digital Pcr Market

Request Now !

The global digital polymerase chain reaction market generated $508.8 million in 2020, and is projected to reach $1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.

Because of global pandemic, significant rise in demand for the ddPCR systems and SARS-CoV-2 kits, owing to various factors such as higher sensitivity of ddPCR, lack of inhibition from sample types, and ease in understanding the results. Moreover, several key players acquired the U.S. Food and Drug Administration (FDA) Emergency Use Authorization for their dPCR test kits to meet imperative requirement of the diagnostic tests for the COVID-19, owing to the rise in demand.

Digital PCR (dPCR) is a simple and reproducible method that does not rely on a calibration curve for sample target quantification. It allows precise, highly sensitive quantification of nucleic acids. In addition, it is used for absolute quantification and analysis of minority sequences. This type of PCR enhances the sensitivity of real-time PCR and detects rare events such as single nucleotide mutations in a population of wild type sequences. dPCR is considered to be a crucial tool in cancer studies, diagnosis, personalized treatment, patient monitoring, and follow-up management.

digital-pcr-market-1619526207

Get more information on this report : Request Sample Pages

The factors that drive the growth of the digital polymerase chain reaction market include rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. In addition, advancements in technology are expected to boost the market growth during the forecast period. However, high cost of dPCR devices and reimbursement issues are the factors expected to hamper the market growth during the forecast period. Conversely, increase in funding for R&D activities is expected to offer potential growth opportunities for market players. The impact of the driving factors is expected to surpass that of the restraints.

COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. The necessity of a highly sensitive molecular diagnosis is expected to considerably reduce false negatives reverse transcription PCR (rtPCR) results, raised as a major clinical need for a robust diagnostic tool for the detection of COVID-19 owing to the global pandemic. Since the COVID-19 pandemic, there have been significant researches published in favor of dPCR over qPCR for COVID-19 testing. There has been significant rise in demand for the ddPCR systems and SARS-CoV-2 kits, owing to various factors such as higher sensitivity of ddPCR, lack of inhibition from sample types, and ease in understanding the results. Moreover, several key players acquired the U.S. Food and Drug Administration (FDA) Emergency Use Authorization for their dPCR test kits to meet imperative requirement of the diagnostic tests for COVID-19, owing to rise in demand. For instance, in June 2020, Stilla offers a dPCR solution named Naica system.

It detects COVID-19 infections sensitively and accurately than the current RT-PCR method. This is the world's first six-color dPCR instrument, the six-color Prism. The instrument expands the multiplexing capabilities of the company's dPCR platform. It is combined with a COVID-19 detection kit, and is able to quickly, accurately, and reliably identify the SARS-CoV-2 virus, as well as measure its viral load. 

By technology, the market is bifurcated into droplet digital PCR (ddPCR), Chip Based Digital PCR and BEAMing digital PCR. Depending on product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan and rest of Asia-Pacific) and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

Technology segment review

Depending on technology, the market is bifurcated into droplet digital PCR (ddPCR), chip based digital PCR and BEAMing digital PCR. The ddPCR segment was the major revenue contributor in 2020, owing to the fact that ddPCR technique provides a precise measure of DNA molecules through each drop. In addition, massive sample partitioning is a key aspect of the droplet digital PCR technique, which increases the demand.

Digital PCR Market
By Technology

Your browser does not support the canvas element.

Droplet Digital PCR segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Product type segment review

On the basis of product type, the market is categorized into digital PCR systems, consumables & reagents, and software & services. The software & services segment is projected to exhibit the fastest growth during the forecast period, as the software helps improve the efficiency of management of digital PCR data. Thus, there is an increase in the demand for these products, thereby propelling the market growth.

Digital PCR Market
By Product Type

Your browser does not support the canvas element.

Topical Medication Segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

North America was the leading revenue contributor to the global digital polymerase chain reaction market in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to its well-developed healthcare industry, presence of leading molecular diagnostics manufacturers in the region, and rise in number of patients using personalized medicines. However, Asia-Pacific is expected to grow at the highest CAGR of 14.45% during the forecast period, as it offers lucrative opportunities for molecular diagnostics players, due to increase in number of patients suffering from chronic diseases and improvement in healthcare facilities in the region.

Digital PCR Market
By Region

2028
North America 
Europe
Asia-pacific
Lamea

Asia Pacific region would exhibit the highest CAGR of 11.5% during 2021-2028.

Get more information on this report : Request Sample Pages

Some of the key players operating in the global digital polymerase chain reaction market include Bio-Rad Laboratories, Inc., 4basebio AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V., Stilla Technologies, Sysmex Corporation, Combinati, Inc., and Thermo Fisher Scientific, Inc. Product launch and acquisition were the most common strategies adopted among key players to expand their product offerings and strengthen their foothold in the global market.

Key Benefits For Stakeholders

  • This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.
  • Quantitative analysis of the current trends and future estimations assist stakeholders to design business strategies accordingly. 
  • Porter’s five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
  • Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.

Key Market Segments

By Technology

  • Droplet Digital PCR
  • Chip Based Digital PCR
  • BEAMing Digital PCR

By Product Type

  • Digital PCR Systems
  • Consumables & Reagents
  • Software & Services

By Application

  • Research
  • Clinical Diagnostics
  • Forensic & Others

By End User

  • Pharmaceuticals & Biotechnology Industries
  • Clinical Diagnostic Laboratories
  • Universities & Other Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in prevalence of infectious diseases and cancer
3.5.1.2.Increase in awareness and acceptance of personalized medicines
3.5.1.3.Technological advancements

3.5.2.Restraints

3.5.2.1.High cost of dPCR devices
3.5.2.2.Reimbursement issues

3.5.3.Opportunity

3.5.3.1.Increase in funding for R&D activities

3.6.NGS technology Impact on Digital PCR Market
3.7.Impact analysis of COVID-19 on the digital PCR market

CHAPTER 4:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY

4.1.Overview

4.1.1.Market size and forecast
4.1.2.Market size and forecast for PCR Market, 2017-2023

4.2.Droplet digital PCR

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Chip based digital PCR

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.BEAMing dPCR

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Consumables & reagents

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Digital PCR systems

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Software & services

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

CHAPTER 6:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Research

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Clinical diagnostics

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Forensic & others

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Clinical diagnostic laboratories

7.2.1.Market size and forecast
7.2.2.Market analysis, by country

7.3.Pharmaceuticals & biotechnology industries

7.3.1.Market size and forecast
7.3.2.Market analysis, by country

7.4.Universities & other organizations

7.4.1.Market size and forecast
7.4.2.Market analysis, by country

CHAPTER 8:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.North America digital PCR market, by country

8.2.2.1.U.S. digital PCR market, by technology
8.2.2.2.U.S. digital PCR market, by product type
8.2.2.3.U.S. digital PCR market, by application
8.2.2.4.U.S. digital PCR market, by end user
8.2.2.5.Canada digital PCR market, by technology
8.2.2.6.Canada digital PCR market, by product type
8.2.2.7.Canada digital PCR market, by application
8.2.2.8.Canada digital PCR market, by end user
8.2.2.9.Mexico digital PCR market, by technology
8.2.2.10.Mexico digital PCR market, by product type
8.2.2.11.Mexico digital PCR market, by application
8.2.2.12.Mexico digital PCR market, by end user

8.2.3.North America digital PCR market, by technology
8.2.4.North America digital PCR market, by product type
8.2.5.North America digital PCR market, by application
8.2.6.North America digital PCR market, by end user

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Europe digital PCR market, by country

8.3.2.1.Germany digital PCR market, by technology
8.3.2.2.Germany digital PCR market, by product type
8.3.2.3.Germany digital PCR market, by application
8.3.2.4.Germany digital PCR market, by end user
8.3.2.5.France digital PCR market, by technology
8.3.2.6.France digital PCR market, by product type
8.3.2.7.France digital PCR market, by application
8.3.2.8.France digital PCR market, by end user
8.3.2.9.UK digital PCR market, by technology
8.3.2.10.UK digital PCR market, by product type
8.3.2.11.UK digital PCR market, by application
8.3.2.12.UK digital PCR market, by end user
8.3.2.13.Italy digital PCR market, by technology
8.3.2.14.Italy digital PCR market, by product type
8.3.2.15.Italy digital PCR market, by application
8.3.2.16.Italy digital PCR market, by end user
8.3.2.17.Spain digital PCR market, by technology
8.3.2.18.Spain digital PCR market, by product type
8.3.2.19.Spain digital PCR market, by application
8.3.2.20.Spain digital PCR market, by end user
8.3.2.21.Rest of Europe digital PCR market, by technology
8.3.2.22.Rest of Europe digital PCR market, by product type
8.3.2.23.Rest of Europe digital PCR market, by application
8.3.2.24.Rest of Europe digital PCR market, by end user

8.3.3.Europe digital PCR market, by technology
8.3.4.Europe digital PCR market, by product type
8.3.5.Europe digital PCR market, by application
8.3.6.Europe digital PCR market, by end user

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Asia-Pacific digital PCR market, by country

8.4.2.1.Japan digital PCR market, by technology
8.4.2.2.Japan digital PCR market, by product type
8.4.2.3.Japan digital PCR market, by application
8.4.2.4.Japan digital PCR market, by end user
8.4.2.5.China digital PCR market, by technology
8.4.2.6.China digital PCR market, by product type
8.4.2.7.China digital PCR market, by application
8.4.2.8.China digital PCR market, by end user
8.4.2.9.Australia digital PCR market, by technology
8.4.2.10.Australia digital PCR market, by product type
8.4.2.11.Australia digital PCR market, by application
8.4.2.12.Australia digital PCR market, by end user
8.4.2.13.India digital PCR market, by technology
8.4.2.14.India digital PCR market, by product type
8.4.2.15.India digital PCR market, by application
8.4.2.16.India digital PCR market, by end user
8.4.2.17.South Korea digital PCR market, by technology
8.4.2.18.South Korea digital PCR market, by product type
8.4.2.19.South Korea digital PCR market, by application
8.4.2.20.South Korea digital PCR market, by end user
8.4.2.21.Taiwan digital PCR market, by technology
8.4.2.22.Taiwan digital PCR market, by product type
8.4.2.23.Taiwan digital PCR market, by application
8.4.2.24.Taiwan digital PCR market, by end user
8.4.2.25.Rest of Asia-Pacific digital PCR market, by technology
8.4.2.26.Rest of Asia-Pacific digital PCR market, by product type
8.4.2.27.Rest of Asia-Pacific digital PCR market, by application
8.4.2.28.Rest of Asia-Pacific digital PCR market, by end user

8.4.3.Asia-Pacific digital PCR market, by technology
8.4.4.Asia-Pacific digital PCR market, by product type
8.4.5.Asia-Pacific digital PCR market, by application
8.4.6.Asia-Pacific digital PCR market, by end user

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.LAMEA digital PCR market, by country

8.5.2.1.Brazil digital PCR market, by technology
8.5.2.2.Brazil digital PCR market, by product type
8.5.2.3.Brazil digital PCR market, by application
8.5.2.4.Brazil digital PCR market, by end user
8.5.2.5.Saudi Arabia digital PCR market, by technology
8.5.2.6.Saudi Arabia digital PCR market, by product type
8.5.2.7.Saudi Arabia digital PCR market, by application
8.5.2.8.Saudi Arabia digital PCR market, by end user
8.5.2.9.South Africa digital PCR market, by technology
8.5.2.10.South Africa digital PCR market, by product type
8.5.2.11.South Africa digital PCR market, by application
8.5.2.12.South Africa digital PCR market, by end user
8.5.2.13.Rest of LAMEA digital PCR market, by technology
8.5.2.14.Rest of LAMEA digital PCR market, by product type
8.5.2.15.Rest of LAMEA digital PCR market, by application
8.5.2.16.Rest of LAMEA digital PCR market, by end user

8.5.3.LAMEA digital PCR market, by technology
8.5.4.LAMEA digital PCR market, by product type
8.5.5.LAMEA digital PCR market, by application
8.5.6.LAMEA digital PCR market, by end user

CHAPTER 9:COMPANY PROFILES

9.1.4BASEBIO AG

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business Performance

9.2.BIO-RAD LABORATORIES, INC.

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.COMBINATI, INC.

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments

9.4.FLUIDIGM CORPORATION

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance

9.5.JN MEDSYS

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments

9.6.MERCK KGAA

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments

9.7.QIAGEN N.V.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segment
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.SYSMEX CORPORATION

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance

9.9.STILLA TECHNOLOGIES

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments

9.10.THERMO FISHER SCIENTIFIC, INC.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance

LIST OF TABLES

TABLE 01.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 02.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 03.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY, 2020–2028 ($MILLION)
TABLE 04.GLOBAL POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, 2016-2023 ($MILLION)
TABLE 05.DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 06.CHIP BASED DIGITAL PCR MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 07.BEAMING PCR MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2020–2028 ($MILLION)
TABLE 09.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY REGION, 2020–2028 ($MILLION)
TABLE 10.DIGITAL PCR SYSTEMS MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 11.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICES, BY REGION, 2020–2028 ($MILLION)
TABLE 12.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 13.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY REGION, 2020–2028 ($MILLION)
TABLE 14.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2020–2028 ($MILLION)
TABLE 15.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS, BY REGION, 2020–2028 ($MILLION)
TABLE 16.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 17.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2020–2028 ($MILLION)
TABLE 18.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY REGION, 2020–2028 ($MILLION)
TABLE 19.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY REGION, 2020–2028 ($MILLION)
TABLE 20.DIGITAL PCR MARKET REVENUE, BY REGION, 2020–2028($MILLION)
TABLE 21.NORTH AMERICA DIGITAL PCR MARKET, BY COUNTRY, 2020–2028($MILLION)
TABLE 22.U.S. DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 23.U.S. DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 24.U.S. DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 25.U.S. DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 26.CANADA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 27.CANADA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 28.CANADA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 29.CANADA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 30.MEXICO DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 31.MEXICO DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 32.MEXICO DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 33.MEXICO DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 34.NORTH AMERICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 35.NORTH AMERICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 36.NORTH AMERICA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 37.NORTH AMERICA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 38.EUROPE DIGITAL PCR MARKET, BY COUNTRY, 2020–2028($MILLION)
TABLE 39.GERMANY DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 40.GERMANY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 41.GERMANY DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 42.GERMANY DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 43.FRANCE DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 44.FRANCE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 45.FRANCE DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 46.FRANCE DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 47.UK DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 48.UK DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 49.UK DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 50.UK DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 51.ITALY DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 52.ITALY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 53.ITALY DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 54.ITALY DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 55.SPAIN DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 56.SPAIN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 57.SPAIN DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 58.SPAIN DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 59.REST OF EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 60.REST OF EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 61.REST OF EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 62.REST OF EUROPE DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 63.EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 64.EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 65.EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 66.EUROPE DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 67.ASIA-PACIFIC DIGITAL PCR MARKET, BY COUNTRY, 2020–2028($MILLION)
TABLE 68.JAPAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 69.JAPAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 70.JAPAN DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 71.JAPAN DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 72.CHINA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 73.CHINA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 74.CHINA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 75.CHINA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 76.AUSTRALIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 77.AUSTRALIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 78.AUSTRALIA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 79.AUSTRALIA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 80.INDIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 81.INDIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 82.INDIA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 83.INDIA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 84.SOUTH KOREA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 85.SOUTH KOREA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 86.SOUTH KOREA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 87.SOUTH KOREA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 88.TAIWAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 89.TAIWAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 90.TAIWAN DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 91.TAIWAN DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 92.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 93.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 94.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 95.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 96.ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 97.ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 98.ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 99.ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 100.LAMEA DIGITAL PCR MARKET, BY COUNTRY, 2020–2028($MILLION)
TABLE 101.BRAZIL DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 102.BRAZIL DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 103.BRAZIL DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 104.BRAZIL DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 105.SAUDI ARABIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 106.SAUDI ARABIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 107.SAUDI ARABIA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 108.SAUDI ARABIA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 109.SOUTH AFRICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 110.SOUTH AFRICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 111.SOUTH AFRICA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 112.SOUTH AFRICA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 113.REST OF LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 114.REST OF LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 115.REST OF LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 116.REST OF LAMEA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 117.LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2020–2028($MILLION)
TABLE 118.LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2020–2028($MILLION)
TABLE 119.LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2020–2028($MILLION)
TABLE 120.LAMEA DIGITAL PCR MARKET, BY END USER, 2020–2028($MILLION)
TABLE 121.4BASEBIO: COMPANY SNAPSHOT
TABLE 122.4BASEBIO: PRODUCT PORTFOLIO
TABLE 123.BIO-RAD: COMPANY SNAPSHOT
TABLE 124.BIO-RAD: OERATING SEGMENT
TABLE 125.BIO-RAD: PRODUCT PORTFOLIO
TABLE 126.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127.COMBINATI: COMPANY SNAPSHOT
TABLE 128.COMBINATI: PRODUCT PORTFOLIO
TABLE 129.COMBINATI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130.FLUIDIGM: COMPANY SNAPSHOT
TABLE 131.FLUIDIGM: PRODUCT PORTFOLIO
TABLE 132.JN MEDSYS: COMPANY SNAPSHOT
TABLE 133.JN MEDSYS: PRODUCT PORTFOLIO
TABLE 134.MERCK: COMPANY SNAPSHOT
TABLE 135.MERCK: OPERATING SEGMENTS
TABLE 136.MERCK: PRODUCT PORTFOLIO
TABLE 137.QIAGEN: COMPANY SNAPSHOT
TABLE 138.QIAGEN: PRODUCT SEGMENT
TABLE 139.QIAGEN: PRODUCT PORTFOLIO
TABLE 140.SYSMEX: COMPANY SNAPSHOT
TABLE 141.SYSMEX: OERATING SEGMENT
TABLE 142.SYSMEX.: PRODUCT PORTFOLIO
TABLE 143.STILLA: COMPANY SNAPSHOT
TABLE 144.STILLA: PRODUCT PORTFOLIO
TABLE 145.THERMO FISHER: COMPANY SNAPSHOT
TABLE 146.THERMO FISHER.: OERATING SEGMENT
TABLE 147.THERMO FISHER.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.SEGMENTATION OF GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET
FIGURE 02.TOP INVESTMENT POCKETS, 2020
FIGURE 03.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.HIGH THREAT OF SUBSTITUTION
FIGURE 06.LOW THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: TOP PLAYER POSITIONING, 2020
FIGURE 09.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2020 & 2027 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF CHIP BASED DIGITAL PCR MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF BEAMING PCR MARKET, BY COUNTRY, 2020 & 2027 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIGITAL PCR SYSTEMS MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICE, BY COUNTRY, 2020 & 2028 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH,  BY COUNTRY, 2020 & 2028 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS,  BY COUNTRY, 2020 & 2028 (%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020 & 2028 (%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY COUNTRY, 2020 & 2028
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 22.4BASEBIO: NET SALES, 2017–2019 ($MILLION)
FIGURE 23.BIO-RAD: NET SALES, 2018–2020 ($MILLION)
FIGURE 24.BIO-RAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.BIO-RAD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26.FLUIDIGM: NET SALES, 2018-2020 ($MILLION)
FIGURE 27.FLUIDIGM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 28.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.MERCK: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 30.MERCK: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 31.QIAGEN: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.QIAGEN: REVENUE SHARE, BY PRODUCT, 2020 (%)
FIGURE 33.QIAGEN: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 34.SYSMEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.SYSMEX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.SYSMEX: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.THERMO FISHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.THERMO FISHER: REVENUE SHARE BY REGION, 2020 (%)

 
 

dPCR is anticipated to witness a significant rise with technological advancements. In addition, other factors that boost the growth of the market include rise in prevalence of infectious diseases, outbreak of COVID-19 pandemic, and increase in awareness & acceptance of personalized medicines. 

Furthermore, increase in economic strength of the developing nations, such as Japan, China, India, Indonesia, and Thailand, as well as rise in healthcare expenditure are also expected to drive the market growth during the forecast period. 

Rapid surge was observed in the adoption of technologically advanced medical devices across developing economies, which is expected to offset the challenging conditions in mature markets, such as North America and Europe. Moreover, North America and Europe are expected to dominate the market during the forecast period, while emerging countries in Asia-Pacific and Latin America are expected to offer potential growth opportunities for the market growth.

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Digital PCR Market is $508.8 million in 2020.

A. The forcast period for Digital PCR Market is 2021 to 2028

A. The market value of Digital PCR Market in 2021 is $620.7 million.

A. The base year is 2020 in Digital PCR Market

A. Top companies such as, Bio-Rad Laboratories, Inc., 4basebio AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen N.V., Stilla Technologies, Sysmex Corporation, Combinati, Inc., and Thermo Fisher Scientific, Inc.

A. The ddPCR segment was the major revenue contributor in 2020, owing to the fact that ddPCR technique provides a precise measure of DNA molecules through each drop. In addition, massive sample partitioning is a key aspect of the droplet digital PCR technique, which increases the demand.

A. The major factor that fuels the growth of the Digital PCR Market owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. In addition, advancements in the technique are anticipated to boost the market growth during the forecast period

A. No, there is no value chain analysis provided in the Digital PCR Market report

A. Digital polymerase chain reaction (dPCR) is a new approach for the detection and quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in the research (basic research and applied research), clinical diagnostics, forensics, and other similar arenas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.

A. Yes, Digital PCR companies are profiled in the report.

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Digital PCR Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers